LivaNova plc Stock
LivaNova plc Stock
LivaNova plc gained 0.980% compared to yesterday.
LivaNova plc is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
With a target price of 59 € there is a slightly positive potential of 14.56% for LivaNova plc compared to the current price of 51.5 €.
Pros and Cons of LivaNova plc in the next few years
Pros
?
M***** P*******
?
B****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of LivaNova plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| LivaNova plc | 0.980% | -3.604% | -2.727% | 50.281% | 1.905% | 36.480% | -17.054% |
| Bio-Rad Labs Inc. A | 1.210% | -3.234% | -5.697% | 1.434% | -9.500% | -49.371% | -50.128% |
| Neogen Corp. | -3.070% | -13.298% | -9.945% | -6.857% | 32.520% | - | - |
| CONMED Corp. | 0.000% | -7.821% | -3.509% | -41.593% | -5.714% | -63.128% | -68.269% |
Comments
LivaNova (LIVN) had its price target raised by Needham & Company LLC from $64.00 to $81.00. They now have a "buy" rating on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova (NASDAQ:LIVN) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Stifel Nicolaus from $65.00 to $70.00. They now have a "buy" rating on the stock.
Show more
Ratings data for LIVN provided by MarketBeat